{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:10:26Z","timestamp":1760775026685,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012990","name":"Universit\u00e0 degli Studi di Siena","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012990","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bmcl.2020.127443","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T21:55:47Z","timestamp":1595886947000},"page":"127443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Structure optimization of positive allosteric modulators of GABAB receptors led to the unexpected discovery of antagonists\/potential negative allosteric modulators"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1998-732X","authenticated-orcid":false,"given":"Claudia","family":"Mugnaini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Brizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafaela","family":"Mostallino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Paola","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5750-4504","authenticated-orcid":false,"given":"Federico","family":"Corelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2020.127443_b0005","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF00237558","article-title":"The action of gamma-aminobutyric acid on cortical neurons","volume":"3","author":"Krnjevi\u0107","year":"1967","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.bmcl.2020.127443_b0010","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1152\/physrev.00036.2003","article-title":"Molecular structure and physiological functions of GABA(B) receptors","volume":"84","author":"Bettler","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bmcl.2020.127443_b0015","doi-asserted-by":"crossref","first-page":"13362","DOI":"10.1074\/jbc.274.19.13362","article-title":"Mutagenesis and modeling of the GABAB receptor extracellular domain support a venus flytrap mechanism for ligand binding","volume":"274","author":"Galvez","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2020.127443_b0020","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1093\/emboj\/20.9.2152","article-title":"Allosteric interactions between GB1 and GB2 subunits are required for optimal GABAB receptor function","volume":"20","author":"Galvez","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.bmcl.2020.127443_b0025","doi-asserted-by":"crossref","first-page":"14649","DOI":"10.1073\/pnas.251554498","article-title":"Function of GB1 and GB2 subunits in G protein coupling of GABAB receptors","volume":"98","author":"Margeta-Mitrovic","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2020.127443_b0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/bcpt.13241","article-title":"The organizing principle of GABAB receptor complexes: physiological and pharmacological implications","volume":"126","author":"Fritzius","year":"2020","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.bmcl.2020.127443_b0035","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1369\/0022155412438105","article-title":"GABAB receptor complex as a potential target for tumor therapy","volume":"60","author":"Jiang","year":"2012","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.bmcl.2020.127443_b0040","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/386239a0","article-title":"Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors","volume":"386","author":"Kaupmann","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2020.127443_b0045","unstructured":"For details about the clinical use of baclofen see Froestl, W. In GABAB Receptor Pharmacology: A Tribute to Norman Bowery; Blackburn, T.P. and Enna, S.J.Ed.; Elsevier Inc., Academic Press, 2010, Vol. 58, pp. 19-62 and references cited therein."},{"issue":"708","key":"10.1016\/j.bmcl.2020.127443_b0050","article-title":"The use of baclofen as a treatment for alcohol use disorder: a clinical practice perspective","volume":"9","author":"de Beaurepaire","year":"2019","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.bmcl.2020.127443_b0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1124\/pr.109.002501","article-title":"Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives","volume":"63","author":"Urwyler","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bmcl.2020.127443_b0060","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1124\/jpet.111.186460","article-title":"Characterization of methyl 2-(1-adamantanecarboxamido)-4-ethyl-5-methylthiophene-3-carboxylate (COR627) and methyl 2-(cyclohexanecarboxamido)-4-ethyl-5-methylthiophene-3-carboxylate (COR628), two novel positive allosteric modulators of the GABAB receptor","volume":"340","author":"Castelli","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmcl.2020.127443_b0065","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1021\/jm400144w","article-title":"Synthesis and pharmacological characterization of 2-(acylamino)thiophene derivatives as metabolically stable, orally effective, positive allosteric modulators of the GABAB receptor","volume":"56","author":"Mugnaini","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2020.127443_b0070","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1039\/C3RA45546G","article-title":"Synthesis, structural properties, and pharmacological evaluation of 2-(acylamino)thiophene-3-carboxamides and analogues thereof","volume":"4","author":"Mugnaini","year":"2014","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmcl.2020.127443_b0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2016.08.032","article-title":"In vitro and in vivo pharmacological characterization of SSD114, a novel GABAB positive allosteric modulator","volume":"791","author":"Porcu","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmcl.2020.127443_b0080","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1007\/s00213-017-4644-3","article-title":"Suppressing effect of COR659 on alcohol, sucrose, and chocolate self-administration in rats: involvement of the GABAB and cannabinoid CB1 receptors","volume":"234","author":"Maccioni","year":"2017","journal-title":"Psycopharmacology"},{"key":"10.1016\/j.bmcl.2020.127443_b0085","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.alcohol.2018.05.007","article-title":"Anti-addictive properties of COR659 \u2013 additional pharmacological evidence and comparison with a series of novel analogues","volume":"75","author":"Maccioni","year":"2019","journal-title":"Alcohol"},{"key":"10.1016\/j.bmcl.2020.127443_b0090","unstructured":"Ferlenghi F, Maccioni P, Mugnaini C, et al. The GABAB receptor positive allosteric modulator COR659: in vitro metabolism, in vivo pharmacokinetics in rats, synthesis and pharmacological characterization of metabolically protected derivatives. Eur J Pharm Sci. Submitted."},{"key":"10.1016\/j.bmcl.2020.127443_b0095","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1124\/jpet.103.053074","article-title":"N, N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) and structurally related compounds: novel allosteric enhancers of gamma-aminobutyric acidB receptor function","volume":"307","author":"Urwyler","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmcl.2020.127443_b0100","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.1016\/j.bmcl.2007.09.023","article-title":"Syntheses and optimization of new GS39783 analogues as positive allosteric modulators of GABA-B receptors","volume":"17","author":"Guery","year":"2007","journal-title":"Bioog Med Chem Lett"},{"key":"10.1016\/j.bmcl.2020.127443_b0105","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/bjp.2008.135","article-title":"Characterization of (R, S)-5,7-di-tert-butyl-3-hydroxy-3-trifl uoromethyl-3H-benzofuran-2-one as a positive allosteric modulator of GABAB receptors","volume":"154","author":"Malherbe","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmcl.2020.127443_b0110","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.1016\/j.bmcl.2007.09.023","article-title":"Syntheses and optimization of new GS39783 analogues as positive allosteric modulators of GABAB receptors","volume":"17","author":"Guerya","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2020.127443_b0115","doi-asserted-by":"crossref","unstructured":"Conn PJ, Scott DK, Doller D. In Drug design strategies for GPCR allosteric modulators; Desai, M.C. Ed.; Academic Press: San Diego, CA, 2012; Vol. 47, pp 441-457 and references cited therein.","DOI":"10.1016\/B978-0-12-396492-2.00028-X"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X20305540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X20305540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:37:13Z","timestamp":1760773033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X20305540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":23,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0960894X20305540"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2020.127443","relation":{},"ISSN":["0960-894X"],"issn-type":[{"type":"print","value":"0960-894X"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure optimization of positive allosteric modulators of GABAB receptors led to the unexpected discovery of antagonists\/potential negative allosteric modulators","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2020.127443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"127443"}}